| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.47.3.696 |
| P698 | PubMed publication ID | 8797467 |
| P2093 | author name string | Bonavita S | |
| Tedeschi G | |||
| Chase TN | |||
| Di Chiro G | |||
| Patronas NJ | |||
| Bertolino A | |||
| Duyn JH | |||
| Metman LV | |||
| Lundbom N | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathology | Q7208 |
| Alzheimer's disease | Q11081 | ||
| P304 | page(s) | 696-704 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging | |
| P478 | volume | 47 |
| Q33526779 | Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder |
| Q24594531 | Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play |
| Q37365638 | Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain |
| Q44435570 | Combined MR measurements of magnetization transfer, tissue diffusion and proton spectroscopy. A feasibility study with neurological cases |
| Q37486254 | Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease |
| Q35677174 | Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging |
| Q35451757 | Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study |
| Q48551159 | Fast spectroscopic imaging using online optimal sparse k-space acquisition and projections onto convex sets reconstruction |
| Q41614051 | In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging |
| Q44212244 | Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy |
| Q44416923 | MR spectroscopy in Alzheimer's disease: gender differences in probabilistic learning capacity |
| Q30660816 | Magnetic resonance imaging and magnetic resonance spectroscopy in dementias |
| Q30630699 | Magnetic resonance spectroscopy in Alzheimer's disease |
| Q30660402 | Magnetic resonance spectroscopy in common dementias |
| Q44780808 | Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy |
| Q30579189 | Proton MRS in neurological disorders |
| Q36318459 | Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease |
| Q30579218 | Proton magnetic resonance spectroscopy in schizophrenia |
| Q37407266 | Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study |
| Q48560409 | Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. |
| Q35749793 | Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD |
| Q44698504 | Straightforward relative quantitation and age-related human standards of N-acetylaspartate at the centrum semiovale level by CSI (1)H-MRS. |
| Q35933438 | Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy |
| Q31864336 | The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia |
| Q35012661 | The need for speed: an update on methamphetamine addiction |
| Q34787071 | Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? |
| Q35781558 | Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). |
| Q35467884 | White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging |
Search more.